Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-509-5 | CAS number: 96-48-0
Endpoint summary
Administrative data
Description of key information
90-Day NOAEL (Oral, rat): 225 mg/kg bw
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 225 mg/kg bw/day
Additional information
In a 90-day subchronic toxicity study on rats and mice exposed by oral gavage to γ-Butyrolactone (NTP, 1992), no substance-related gross or microscopic lesions were observed at doses up to 900 mg/kg bw (rats) and 1050 mg/kg bw (mice), given 5 days per week. For male rats, a NOAEL of 225 mg/kg bw was reported based on decreased mean body weights and weight gains, and complete mortality of male rats at 900 mg/kg bw. For female rats, a NOAEL of 450 mg/kg bw was reported based on 1 death in the high dose group. For mice, a NOAEL of 525 mg/kg bw was reported based on decreased mean body weights and weight gains in males and increased mortality in males and females at the 1050 mg/kg bw dose.
Further study of repeat dose toxicity was performed by NTP in conjunction with a 2 year cancer bioassay with rats and mice (NTP 1992). See carcinogenicity section.
Justification for classification or non-classification
In a 90-day subchronic toxicity study on rats and mice exposed by oral gavage to γ-Butyrolactone, no substance-related gross or microscopic lesions were observed at doses up to 900 mg/kg bw (rats) and 1050 mg/kg bw (mice). A NOAEL of 225 and 450 mg/kg bw was reported for male and female rats, respectively based on decreased mean body weights and weight gains in the mid and high dose males, and on mortality in the high dose males and females. For mice, a NOAEL of 525 mg/kg bw was reported based on decreased mean body weights and weight gains in males and increased mortality in males and females at the 1050 mg/kg bw dose. Gamma butyrolactone does not meet the requirements for classification under the EU DSD (EU Directive 67/548/EEC) nor would classification for Specific Target Organ Toxicity, repeated exposure, be required under the EU CLP criteria (EU Regulation 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
